Total Payments
$7,776
2024 Payments
$950.51
Companies
39
Transactions
275
Medicare Patients
13,375
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$7,769 (99.9%)
Education$6.97 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,769 | 274 | 99.9% |
| Education | $6.97 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,356 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $708.26 | 53 | $0 (2024) |
| Amgen Inc. | $651.10 | 49 | $0 (2022) |
| ABIOMED | $605.76 | 9 | $0 (2023) |
| Penumbra, Inc. | $567.86 | 5 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $520.13 | 31 | $0 (2024) |
| ShockWave Medical, Inc | $466.19 | 4 | $0 (2023) |
| HeartFlow, Inc. | $393.80 | 5 | $0 (2022) |
| PFIZER INC. | $370.09 | 24 | $0 (2024) |
| Cardiovascular Systems Inc. | $298.53 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $950.51 | 26 | Boston Scientific Corporation ($238.24) |
| 2023 | $1,458 | 50 | Boston Scientific Corporation ($364.12) |
| 2022 | $939.01 | 22 | BOSTON SCIENTIFIC CORPORATION ($296.15) |
| 2021 | $640.02 | 25 | Medtronic, Inc. ($119.80) |
| 2020 | $451.14 | 8 | HeartFlow, Inc. ($168.21) |
| 2019 | $966.31 | 37 | Boston Scientific Corporation ($182.14) |
| 2018 | $1,253 | 46 | ABIOMED ($254.22) |
| 2017 | $1,118 | 61 | Amgen Inc. ($274.06) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $105.78 | General |
| Category: Renal Denervation System | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $38.48 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $110.61 | General |
| Category: SYNERGY_IC | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $127.63 | General |
| Category: AVVIGO_IC | ||||||
| 08/21/2024 | BIOTRONIK INC. | Orsiro Mission (Device) | Food and Beverage | In-kind items and services | $123.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $37.83 | General |
| Category: NEUROLOGY | ||||||
| 07/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Medical Device | ||||||
| 04/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $59.45 | General |
| Category: VTE | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,392 | 4,202 | $792,498 | $316,092 |
| 2022 | 31 | 3,346 | 4,274 | $802,296 | $312,279 |
| 2021 | 37 | 3,552 | 4,632 | $865,892 | $347,315 |
| 2020 | 34 | 3,085 | 4,023 | $769,798 | $318,813 |
Total Patients
13,375
Total Services
17,131
Medicare Billing
$1.3M
Procedure Codes
132
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 630 | 815 | $125,510 | $49,564 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 376 | 487 | $106,166 | $41,845 | 39.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 109 | 109 | $82,295 | $36,729 | 44.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 265 | 267 | $90,025 | $36,053 | 40.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 44 | 53 | $51,776 | $21,593 | 41.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 116 | 116 | $55,912 | $20,676 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $46,008 | $18,187 | 39.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 108 | 108 | $35,532 | $13,738 | 38.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 71 | 284 | $16,330 | $10,842 | 66.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 68 | 68 | $25,432 | $10,669 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 80 | $24,480 | $9,413 | 38.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 644 | 705 | $18,330 | $6,950 | 37.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 106 | 112 | $14,840 | $5,783 | 39.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 109 | 109 | $13,625 | $5,170 | 37.9% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 22 | 22 | $12,950 | $4,405 | 34.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 67 | $9,045 | $3,997 | 44.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 40 | $8,840 | $3,978 | 45.0% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $9,180 | $3,794 | 41.3% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $8,205 | $3,389 | 41.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 17 | 17 | $7,038 | $3,059 | 43.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,835 | $1,645 | 42.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 120 | 124 | $2,728 | $1,191 | 43.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 18 | 18 | $2,538 | $926.05 | 36.5% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 36 | 36 | $1,656 | $705.36 | 42.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 26 | 165 | $1,650 | $693.00 | 42.0% |
About Dr. George Khammar, MD
Dr. George Khammar, MD is a Cardiovascular Disease healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619927373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Khammar, MD has received a total of $7,776 in payments from pharmaceutical and medical device companies, with $950.51 received in 2024. These payments were reported across 275 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,769).
As a Medicare-enrolled provider, Khammar has provided services to 13,375 Medicare beneficiaries, totaling 17,131 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Fort Worth, TX
- Active Since 05/11/2006
- Last Updated 10/11/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1619927373
Products in Payments
- ELIQUIS (Drug) $722.13
- Corlanor (Drug) $607.18
- Impella (Device) $605.76
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $466.19
- Indigo (Device) $451.12
- AVVIGO Guidance System (Device) $297.65
- CAMZYOS (Drug) $285.99
- ENTRESTO (Drug) $267.73
- Resolute (Device) $254.13
- LEQVIO (Drug) $252.40
- FFRct (Device) $225.59
- BRILINTA (Drug) $200.01
- Coronary Orbital Atherectomy System (Device) $197.32
- OptiCross (Device) $190.43
- XARELTO (Drug) $163.75
- CROSSBOSS (Device) $141.58
- General - Therapies (Device) $140.04
- Orsiro Mission (Device) $123.89
- Indigo System (Device) $116.74
- OPTICROSS (Device) $111.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fort Worth
Elizabeth Holper, M.d, M.D
Cardiovascular Disease — Payments: $434,185
Cardiovascular Disease $434,185
Dr. Mohanakrishnan Sathyamoorthy, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Dr. Senthil Thambidorai, M.d, M.D
Cardiovascular Disease — Payments: $230,744
Cardiovascular Disease $230,744
Sukesh Burjonroppa, M.d, M.D
Cardiovascular Disease — Payments: $194,389
Cardiovascular Disease $194,389
Dr. Aleem Mughal, Md, MD
Cardiovascular Disease — Payments: $91,055
Cardiovascular Disease $91,055
Mehmet Cilingiroglu, M.d, M.D
Cardiovascular Disease — Payments: $44,151
Cardiovascular Disease $44,151